Antisense Pharma Raises €13 Million
Antisense Pharma, a German developer of cancer therapeutics, has raised €13 million in new VC funding. Return backers included MIG Fonds and the Global Asset Fund.
15 March 2010•7 mins read
Antisense Pharma, a German developer of cancer therapeutics, has raised €13 million in new VC funding. Return backers included MIG Fonds and the Global Asset Fund.
